Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Elisa Mura1 Department of Drug Sciences, Centre of Excellence in Applied Biology, University of Pavia, Pavia, ItalyCorrespondence[email protected]

Stefano Govoni1 Department of Drug Sciences, Centre of Excellence in Applied Biology, University of Pavia, Pavia, Italy

Marco Racchi1 Department of Drug Sciences, Centre of Excellence in Applied Biology, University of Pavia, Pavia, Italy

Valeria Carossa1 Department of Drug Sciences, Centre of Excellence in Applied Biology, University of Pavia, Pavia, Italy

Guglielmina Nadia Ranzani2 Department of Biology and Biotechnology, University of Pavia, Pavia, Italy

Massimo Allegri3 Pain Therapy Service, Foundation IRCCS San Matteo Hospital, Pavia, Italy;4 Department of Clinical, Surgical Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy

Ron HN van Schaik5 Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands

show all

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date